Main navigation
Search Results
-
-
Press release - 15/11/2024 Selenium proteins as a possible new target for cancer research
An important enzyme helps the body produce selenium proteins – this discovery could open up new strategies for treating cancer in children. This has been published by scientists from the University of Würzburg, the University Sao Paolo, the German Cancer Research Center (DKFZ) and the Heidelberg Stem Cell Institute HI-STEM*.
https://www.gesundheitsindustrie-bw.de/en/article/press-release/selenium-proteins-possible-new-target-cancer-research -
Press release - 15/11/2024 Patient association raises 10,000 euros for work on PURA syndrome - Donation for research into rare neuronal developmental disorder at Ulm University
PURA syndrome is a rare developmental disorder of the brain for which there is currently no cure. The patient association PURA Syndrome Germany was founded last year. Since then, the affected families have been collecting donations with great dedication – and have decided to donate the majority of this money to research into the syndrome at Ulm University.
https://www.gesundheitsindustrie-bw.de/en/article/press-release/patient-association-raises-10000-euros-work-pura-syndrome-donation-research-rare-neuronal-developmental-disorder-ulm-university -
Press release - 14/11/2024 Novel method for fighting tumors
Making existing cancer therapy more efficient while significantly reducing the side effects on healthy tissue - this is the aim of a project at Aalen University. It is being funded with one million euros from the Carl Zeiss Foundation. The biophysicist and his team are developing innovative nanoparticles made of gold. The particles use radiotherapy and chemotherapy simultaneously and kill the cancer cells in a targeted manner.
https://www.gesundheitsindustrie-bw.de/en/article/press-release/novel-method-for-fighting-tumors -
Advancing quantum technology into real-world applications - 06/11/2024 QSens: BMBF future cluster brings quantum sensors of the future into medicine
The BMBF-funded future cluster ‘QSens – Quantum Sensors of the Future’ is developing ultra-sensitive sensors that could open up new options in medicine, enabling faster drug research, more accurate diagnostics and improved rehabilitation. The universities of Stuttgart and Ulm are actively working with 17 industry partners to put these cutting-edge innovations to immediate practical use.
https://www.gesundheitsindustrie-bw.de/en/article/news/qsens-bmbf-future-cluster-brings-quantum-sensors-future-medicine -
Press release - 05/11/2024 How biomedical innovation improves preclinical research
3D tumor models, simulations of drug responses or plant stems used for testing heart stents: the 3R-BioMedicUS center at the University of Stuttgart is developing innovative biomedical approaches to improve preclinical studies, to be seen in the new video.
https://www.gesundheitsindustrie-bw.de/en/article/press-release/how-biomedical-innovation-improves-preclinical-research -
Press release - 05/11/2024 Heidelberg scientist receives highly endowed EC synergy grant
Heidelberg scientist Dr Venera Weinhardt has received an ERC Synergy Grant for a pioneering biomedical research project. The European Research Council (ERC) is granting this funding to advance soft X-ray microscopy. This imaging technique along with other innovations will be used to investigate the hepatitis E virus.
https://www.gesundheitsindustrie-bw.de/en/article/press-release/heidelberg-scientist-receives-highly-endowed-ec-synergy-grant -
Press release - 30/10/2024 Diabetes switch in DNA: Non-coding region in the genome influences ONECUT1 gene
They are underestimated genetic control elements: it is known that changes in the genome can trigger diabetes. But now researchers at the University Hospital Ulm and the INSERM Cochin Institute in Paris have shown that a previously under-researched region of the genome also plays a crucial role in the development of this disease.
https://www.gesundheitsindustrie-bw.de/en/article/press-release/diabetes-switch-dna-non-coding-region-genome-influences-onecut1-gene -
NMI project WOUNDSENS - 23/10/2024 Wound monitoring using sensory nanofibres
Monitoring the condition of chronic, non-healing wounds requires wound dressings to be changed at short, regular intervals. In the EU-funded WOUNDSENS project, researchers at the NMI in Reutlingen are using electrospinning to produce novel types of wound dressings. These consist of biosensory fibres that send information about the condition of the wound to the outside, thereby improving inflammation detection.
https://www.gesundheitsindustrie-bw.de/en/article/news/wound-monitoring-using-sensory-nanofibres -
Press release - 16/10/2024 Sensitive Arm Prostheses
A quantum sensor that can register nerve impulses without contact opens up new possibilities in prosthetics. Researchers at Fraunhofer IPA are developing together with the industrial partner Q.ANT the prototype of one Prosthetic arm that is controlled by neural commands like healthy limbs.
https://www.gesundheitsindustrie-bw.de/en/article/press-release/sensitive-arm-prostheses -
Sustainable medical technology - 10/10/2024 Rethinking plastics in medical technology
Good healthcare relies heavily on medical products made from plastic. However, the widespread use of synthetic materials, particularly disposable items, creates vast amounts of waste, depletes resources and leads to a substantial carbon footprint. To create more environmentally friendly plastic products in the future, substantial changes to production processes are essential.
https://www.gesundheitsindustrie-bw.de/en/article/news/rethinking-plastics-medical-technology -
Press release - 09/10/2024 Language model "UroBot“ surpasses the accuracy of experienced urologists
Scientists at the German Cancer Research Center (DKFZ), together with doctors from the Urological Clinic of the Mannheim University Hospital, have developed and successfully tested a chatbot based on artificial intelligence. "UroBot" was able to answer questions from the urology specialist examination with a high degree of accuracy, surpassing both other language models and the accuracy of experienced urologists.
https://www.gesundheitsindustrie-bw.de/en/article/press-release/language-model-urobot-surpasses-accuracy-experienced-urologists -
Event - Networking Evening BW-UK | MEDICA 2024
MEDICA trade-fair, Baden-Württemberg joint-booth H09, Hall 14, Registration deadline: Messehttps://www.gesundheitsindustrie-bw.de/en/event/networking-abend-bw-uk-medica-2024 -
Event - Networking Evening BW-UK | MEDICA 2024
MEDICA trade-fair, Baden-Württemberg joint-booth H09, Hall 14, Registration deadline: Messehttps://www.bio-pro.de/en/events/networking-abend-bw-uk-medica-2024 -
Press release - 01/10/2024 Reporter Skin: In-vitro Skin Makes Cell Reaction to Test Substance Measurable in Real Time
At the Fraunhofer Institute for Interfacial Engineering and Biotechnology IGB, a three-dimensional skin model has now been set up for the first time that directly displays the skin's reaction to substances: The reporter skin. Thanks to the built-in reporter, the cellular response can be measured precisely and quickly – using a living model.
https://www.gesundheitsindustrie-bw.de/en/article/press-release/reporter-skin-vitro-skin-makes-cell-reaction-test-substance-measurable-real-time -
-
Press release - 25/09/2024 How do rare genetic variants affect health? AI provides more accurate predictions
Whether we are predisposed to particular diseases depends to a large extent on the countless variants in our genome. However in the case of genetic variants the influence on the presentation of certain pathological traits has been difficult to determine. Researchers have introduced an algorithm based on deep learning that can predict the effects of rare genetic variants.
https://www.gesundheitsindustrie-bw.de/en/article/press-release/how-do-rare-genetic-variants-affect-health-ai-provides-more-accurate-predictions -
Chronic inflammatory bowel diseases - 25/09/2024 Proinflammatory regulatory T lymphocytes as a therapeutic target in Crohn's disease
Chronic inflammatory bowel diseases are very stressful for those affected and increase the risk of bowel cancer. PD Dr. Robyn Laura Kosinsky from the Bosch Health Campus in Stuttgart, together with researchers from the USA, identified disfunctional regulatory T cells as important drivers of inflammation in Crohn's disease. They also found that with the help of an epigenetically active drug, it was possible to restore the cells’ original…
https://www.gesundheitsindustrie-bw.de/en/article/news/proinflammatory-regulatory-t-lymphocytes-therapeutic-target-crohns-disease -
Press release - 25/09/2024 How developmental signals can contribute to Genomic Mosaicism
Certain developmental signals play a significant role in maintaining our genetic blueprints. They prevent alterations in the genome, known as mosaicism. The underlying biological mechanism helps the DNA to produce an identical copy of itself during cell division using the original genetic blueprint. However, it can also contribute to genomic mosaicism during nerve cell development.
https://www.gesundheitsindustrie-bw.de/en/article/press-release/how-developmental-signals-can-contribute-genomic-mosaicism -
Press release - 23/09/2024 Carl Zeiss Foundation supports early career research group for biohybrid neuroimplants
Dr Simon Binder has been awarded a five-year, 1.5 million euro grant from the Carl Zeiss Foundation for his research into novel neuroimplants. Binder will establish the early career research group ‘Biohybrid Neuroimplants based on Soft Hydrogel Electrodes’ at the University of Freiburg. It is affiliated with the research institutions BrainLinks-BrainTools.
https://www.gesundheitsindustrie-bw.de/en/article/press-release/carl-zeiss-foundation-supports-early-career-research-group-biohybrid-neuroimplants -
Press release - 19/09/2024 Quality standards for looking into the tumor genome
Personalized medicine with individually tailored therapies is becoming more a reality in cancer. This requires a look into the genetic material of tumors, a molecular diagnostic tumor profile. A research group from the German Network for Personalized Medicine (DNPM) has recorded the quality standards according to which genome analyses are carried out in Germany. The data is a prerequisite for integrating gene sequencing into routine care.
https://www.gesundheitsindustrie-bw.de/en/article/press-release/quality-standards-looking-tumor-genome -
Press release - 18/09/2024 Future cluster QSens starts the second round of funding
In the “Cluster4Future” QSens of the Universities of Stuttgart and Ulm, scientists, companies and start-ups are researching quantum sensors with a wide range of potential applications. The Federal Ministry of Education and Research is funding QSens for a further three years as part of “Clusters4Future”.
https://www.gesundheitsindustrie-bw.de/en/article/press-release/future-cluster-qsens-starts-second-round-funding -
Press release - 17/09/2024 Five new cross-border doctoral networks at Universität Heidelberg
Five transnational and cross-institutional doctoral networks at Heidelberg University are being funded as part of the “Marie Skłodowska-Curie Actions”. They work together on current scientific topics with high innovation potential. Ruperto Carola coordinates an MSCA Doctoral Network on artificial intelligence in physics, two networks in medicine, life sciences and engineering.
https://www.gesundheitsindustrie-bw.de/en/article/press-release/five-new-cross-border-doctoral-networks-universitat-heidelberg -
Press release - 12/09/2024 Power-to-vitamins: microbes produce folate from simple basic ingredients
Biotechnology team at University of Tübingen obtains valuable byproduct in protein production. This could be a potential to the contribution of feeding a growing world population without livestock farming.
https://www.gesundheitsindustrie-bw.de/en/article/press-release/power-vitamins-microbes-produce-folate-simple-basic-ingredients -
Press release - 11/09/2024 Researchers combine the power of artificial intelligence and the wiring diagram of a brain to predict brain cell activity
Scientists have long sought ways to simulate the neural networks in the brain with computers in order to understand how it works. Now, researchers have combined new measurements of the wiring diagrams of the fruit fly with artificial intelligence methods to build a neural network that can do what few thought possible: To predict the activity of individual neurons without making a single measurement in a living brain.
https://www.gesundheitsindustrie-bw.de/en/article/press-release/researchers-combine-power-artificial-intelligence-and-wiring-diagram-brain-predict-brain-cell-activity -
BIOPRO Baden-Württemberg publishes first results of a new WifOR study - 11/09/2024 Industrial healthcare industry in Baden-Württemberg: gross value added of more than 19 billion euros
The industrial healthcare sector (iGW) plays a central role in the economy in Baden-Württemberg. In 2021, the sector generated a direct gross value added of 19.6 billion euros, which corresponds to around a third (32.6%) of the entire regional healthcare industry. Of 96.3%, almost all of the healthcare sectors's exports in the state in 2021 came from the iGW. These are the findings of a new study conducted on behalf of BIOPRO…
https://www.gesundheitsindustrie-bw.de/en/article/press-release/industrial-healthcare-industry-baden-wuerttemberg-gross-value-added-more-19-billion-euros -
BIOPRO Baden-Württemberg publishes first results of a new WifOR study - 11/09/2024 Industrial healthcare industry in Baden-Württemberg: gross value added of more than 19 billion euros
The industrial healthcare sector (iGW) plays a central role in the economy in Baden-Württemberg. In 2021, the sector generated a direct gross value added of 19.6 billion euros, which corresponds to around a third (32.6%) of the entire regional healthcare industry. Of 96.3%, almost all of the healthcare sectors's exports in the state in 2021 came from the iGW. These are the findings of a new study conducted on behalf of BIOPRO…
https://www.bio-pro.de/en/information/press-release/industrial-healthcare-industry-baden-wuerttemberg-gross-value-added-more-19-billion-euros -
Press release - 09/09/2024 New Molecular Engineering Technique allows for complex Organoids
A new molecular engineering technique can precisely influence the development of organoids. Microbeads made of specifically folded DNA are used to release growth factors or other signal molecules inside the tissue structures. This gives rise to considerably more complex organoids that imitate the respective tissues much better and have a more realistic cell mix than before.
https://www.gesundheitsindustrie-bw.de/en/article/press-release/new-molecular-engineering-technique-allows-complex-organoids -
Press release - 05/09/2024 Cohesion at the cellular level: flexible yet stable
Research teams from the Universities of Konstanz and Potsdam are analyzing how proteins work together to enable our cells to both stick and move. The marker protein paxillin is at the centre of their interest.
https://www.gesundheitsindustrie-bw.de/en/article/press-release/cohesion-cellular-level-flexible-yet-stable -
Press release - 04/09/2024 Epigenetic changes reprogram astrocytes into brain stem cells
With mice, researchers showed that experimentally induced lack of blood flow in the brain epigenetically reprograms astrocytes into brain stem cells, which in turn can give rise to nerve progenitor cells. This discovery shows that astrocytes could potentially be used in regenerative medicine to replace damaged nerve cells.
https://www.gesundheitsindustrie-bw.de/en/article/press-release/epigenetic-changes-reprogram-astrocytes-brain-stem-cells -
Innovation for sustainable plastic packaging - 04/09/2024 Liquid Plug & Play: eco-designed plastic packaging – not just for ultrasound gel
In the healthcare industry tons of consumables such as ultrasound gel go to waste because packaging can’t be completely emptied. An invention called Liquid Plug & Play could offer a solution for the future. This innovation, which consists of a reusable outer shell and a disposable product pouch for viscous substances, can be completely emptied. It also prevents cross-contamination and offers many other benefits.
https://www.gesundheitsindustrie-bw.de/en/article/news/liquid-plug-und-play-eco-designed-plastic-packaging-not-just-ultrasound-gel -
Press release - 03/09/2024 NMR Spectroscopy: A Faster Way to Determine the “Sense of Rotation” of Molecules
Researchers of Karlsruhe Institute of Technology (KIT) and Voxalytic GmbH developed a new method that allows, for the first time, to elucidate the chiral structure of molecules – the exact spatial arrangement of the atoms – by nuclear magnetic resonance (NMR) spectroscopy. This important step in the development of new drugs used to be a time-consuming process until now.
https://www.gesundheitsindustrie-bw.de/en/article/press-release/nmr-spectroscopy-faster-way-determine-sense-rotation-molecules -
Event - The TechMed Event 2024
TechMed Centre , Kongress/Symposiumhttps://www.gesundheitsindustrie-bw.de/en/event/techmed-event-2024 -
Event - MedTech Twente Week: Explore & Connect fact-finding trip
Enschede, Netherlands , Fact-finding triphttps://www.gesundheitsindustrie-bw.de/en/event/medtech-twente-week-explore-und-connect-fact-finding-trip -
Pipetting robot for academic research - 28/08/2024 goodBot GmbH: a third arm for researchers
Repetitive tasks that researchers have to conduct in the lab tend to be tiring and often lead to errors. Precise pipetting is crucial for achieving reproducible results. Automation is underrepresented in research labs and existing pipetting robots are unsuitable for scientists. This is why Dr. Julius Wiener, Tobias Zundel and Oliver Brunner decided to found the company goodBot GmbH and develop a pipetting robot tailored to academic research.
https://www.gesundheitsindustrie-bw.de/en/article/news/goodbot-gmbh-third-arm-researchers -
Press release - 26/08/2024 Synthetic Immunology: Approaching a Turning Point in the Treatment and Prevention of Disease
Synthetic immunology is the topic of an article in the “Perspectives” section of the journal “Nature Nanotechnology”. Herein, Heidelberg researchers describe a so-called bottom-up approach that uses the toolbox of nanotechnology and synthetic biology to construct systems from molecular building blocks and specifically equip them with immune functions.
https://www.gesundheitsindustrie-bw.de/en/article/press-release/synthetic-immunology-approaching-turning-point-treatment-and-prevention-disease -
Press release - 22/08/2024 Validated targets for personalized cancer immunotherapy
Knowledge of the target structures for the immune cells is a basic prerequisite for the development of personalized cancer immunotherapies. Scientists from the German Cancer Research Center and the NCT Heidelberg are publishing a sensitive method based on mass spectroscopy to identify such tumor-specific "neoepitopes". The analytical method is designed to detect these low abundance protein fragments and requires minimal amounts of…
https://www.gesundheitsindustrie-bw.de/en/article/press-release/validated-targets-personalized-cancer-immunotherapy -
Press release - 21/08/2024 A molecular control hub maintains order
How are proteins in our cells modified while they are still being synthesized? An international team of researchers from the University of Konstanz, Caltech, and ETH Zurich has deciphered the molecular mechanism of this vital process.
https://www.gesundheitsindustrie-bw.de/en/article/press-release/molecular-control-hub-maintains-order -
Event - Lunch & Learn: BW-UK Health Industry Procurement - Building Bridges for Better Healthcare
Online, Registration deadline: Informationsveranstaltunghttps://www.gesundheitsindustrie-bw.de/en/event/lunch-und-learn-bw-uk-health-industry-procurement-building-bridges-better-healthcare -
Event - Lunch & Learn: BW-UK Health Industry Procurement - Building Bridges for Better Healthcare
Online, Registration deadline: Informationsveranstaltunghttps://www.bio-pro.de/en/events/past-events/lunch-und-learn-bw-uk-health-industry-procurement-building-bridges-better-healthcare -
Event - - DigiHealthDay 2024
Deggendorf, Germany, Kongress/Symposiumhttps://www.gesundheitsindustrie-bw.de/en/event/digihealthday-2024 -
Press release - 14/08/2024 New vaccine against cervical cancer combines prophylactic and therapeutic activities
Scientists at the German Cancer Research Center (DKFZ) have developed a completely new vaccination concept. The vaccine is inexpensive and protects mice against almost all cancer-causing HPV types. In addition to preventing new infections, the vaccine also triggers cellular immune responses against HPV-infected cells and may therefore also have a therapeutic effect against existing infections.
https://www.gesundheitsindustrie-bw.de/en/article/press-release/new-vaccine-against-cervical-cancer-combines-prophylactic-and-therapeutic-activities -
Press release - 13/08/2024 Peptide Boronic Acids: New Prospects for Immunology
A cutting-edge chemical process is the first to make it possible to quickly and easily produce modified peptides with boronic acids. As part of this work, scientists managed to synthesize a large number of different biologically active peptide boronic acids and investigate their properties. They open up new possibilities in the young research field of synthetic immunology and could go on to be used primarily in immunotherapy.
https://www.gesundheitsindustrie-bw.de/en/article/press-release/peptide-boronic-acids-new-prospects-immunology -
Start-up Cerebri GmbH - 05/08/2024 Comprehensive EEG supply thanks to telemedicine
Fewer and fewer patients are getting timely access to electroencephalograms, as the process of measuring brain activity and interpreting the results requires specific expertise. Cerebri GmbH, a newly established Tübingen-based company, aims to address this issue by offering user-friendly EEG caps and providing rapid, location-independent and top-tier diagnostics by experts.
https://www.gesundheitsindustrie-bw.de/en/article/news/comprehensive-eeg-supply-thanks-telemedicine -
Press release - 01/08/2024 Targeted therapy for cancer of unknown primary (Cup)
Encouraging results from a large international study led by Heidelberg have recently been published in the journal “Lancet”: The genetic material of cancer cells with unknown tissue of origin contains numerous targets for specific drugs that are already available and have been developed to treat other forms of cancer. These suppressed the disease in CUP patients for significantly longer than chemotherapy.
https://www.gesundheitsindustrie-bw.de/en/article/press-release/targeted-therapy-cancer-unknown-primary-cup -
EU-wide networking of innovation ecosystems for personalised healthcare https://www.bio-pro.de/en/projects/current-projects/preciseu-personalised-medicine-empowerment-connecting-innovation-ecosystems-across-europePRECISEU - PeRsonalised medicine Empowerment Connecting Innovation ecoSystems across EUrope
-
The start of a transnational cooperation for a future of sustainable healthcare - 25/07/2024 BIOPRO is a sustainability partner in the EU HACK-IT-NET project
The HACK-IT-NET (“Health And Care Knowledge and Innovation Transfer NETwork”) project aims to provide holistic and seamless healthcare for all patients in the Alpine region. The project, which was launched in July 2024 and will run for three years, aims to bring together stakeholders in the healthcare sector to create a forward-looking healthcare ecosystem in the Alpine region. BIOPRO is a partner.
https://www.bio-pro.de/en/information/press-release/biopro-sustainability-partner-eu-hack-it-net-project -
Event - DIS&CO Health | Market opportunities in Morocco
Online , Registration deadline: Informationsveranstaltunghttps://www.gesundheitsindustrie-bw.de/en/event/dis-und-co-health-marktchancen-marokko -
Event - DIS&CO Health | Market opportunities in Morocco
Online , Registration deadline: Informationsveranstaltunghttps://www.bio-pro.de/en/events/dis-und-co-health-marktchancen-marokko -
Research association - 24/07/2024 SPI-MP: pioneer in personalised medical technology
Every person is unique – even when they are ill. This is why many approaches to personalised medicine have been under development. The Stuttgart Partnership Initiative - Mass Personalization (SPI-MP), which focuses on basic research into fabrication and biomaterial technologies for personalised biomedical systems, is at the heart of such research work. The projects range from artificial knee joint cartilage to state-of-the-art stroke diagnostics.
https://www.gesundheitsindustrie-bw.de/en/article/news/spi-mp-pioneer-personalised-medical-technology